Flax Pond Capital’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Other funds holding BCYC
BBA
LFCM
Flax Pond Capital's BCYC Position: Q3 2026 in Review
Flax Pond Capital increased its Bicycle Therapeutics (BCYC) stake by 1.7% in Q3 2026, buying an estimated $12.1K and bringing the position to 183,086 shares worth $674K. The position accounts for 0.48% of the portfolio, ranked #43.
Flax Pond Capital first reported a position in BCYC in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.23M in Q4 2025. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.
- Flax Pond Capital held 183,086 shares of Bicycle Therapeutics worth $674K as of Q3 2026.
- Flax Pond Capital bought 3,000 Bicycle Therapeutics shares in Q3 2026, an estimated $12.1K.
- Bicycle Therapeutics made up 0.48% of Flax Pond Capital's portfolio in Q3 2026, its #43 holding.
- Flax Pond Capital first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Flax Pond Capital's Bicycle Therapeutics position peaked at $1.23M in Q4 2025.
- 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.
Based on Flax Pond Capital's 13F filing for Q3 2026, filed 18 Nov 2026.